CXCR4 and cancer: Flow cytometry and fluorescence microscopy analysis revealed that JM173 mediated the specific targeting of CXCR4-overexpressing cancer cells and the cellular uptake and subsequent delivery of active C3 Rho-inhibiting enzyme into their cytosol.